- Home
- BNTC vs TNGX Comparison
BNTC vs TNGX Comparison
Compare BNTC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- TNGX
- Stock Information
- Founded
- BNTC 1995
- TNGX 2014
- Country
- BNTC United States
- TNGX United States
- Employees
- BNTC N/A
- TNGX N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BNTC Health Care
- TNGX Health Care
- Exchange
- BNTC Nasdaq
- TNGX Nasdaq
- Market Cap
- BNTC 339.8M
- TNGX 317.4M
- IPO Year
- BNTC N/A
- TNGX N/A
- Fundamental
- Price
- BNTC $16.11
- TNGX $1.76
- Analyst Decision
- BNTC Strong Buy
- TNGX Strong Buy
- Analyst Count
- BNTC 7
- TNGX 7
- Target Price
- BNTC $24.43
- TNGX $12.33
- AVG Volume (30 Days)
- BNTC 37.6K
- TNGX 801.9K
- Earning Date
- BNTC 05-12-2025
- TNGX 05-07-2025
- Dividend Yield
- BNTC N/A
- TNGX N/A
- EPS Growth
- BNTC N/A
- TNGX N/A
- EPS
- BNTC N/A
- TNGX N/A
- Revenue
- BNTC N/A
- TNGX $42,069,000.00
- Revenue This Year
- BNTC N/A
- TNGX N/A
- Revenue Next Year
- BNTC N/A
- TNGX N/A
- P/E Ratio
- BNTC N/A
- TNGX N/A
- Revenue Growth
- BNTC N/A
- TNGX 15.17
- 52 Week Low
- BNTC $4.75
- TNGX $1.71
- 52 Week High
- BNTC $15.97
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- BNTC 70.37
- TNGX 33.97
- Support Level
- BNTC $14.90
- TNGX $1.80
- Resistance Level
- BNTC $15.97
- TNGX $2.04
- Average True Range (ATR)
- BNTC 1.03
- TNGX 0.18
- MACD
- BNTC 0.32
- TNGX 0.01
- Stochastic Oscillator
- BNTC 85.59
- TNGX 20.19
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.